Drugs / Cannabis oil with a high ratio of THC to CBD
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05261321 Comparator | Oct 2022 → Mar 2026 overdue | — | University of British Columbia | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cannabis oil with a high ratio of THC to CBD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05261321 ↗ |
| Route | Oral | “Participants will be given a single dose of oral cannabis oil containing 5mg THC and 0.17mg CBD.” NCT05261321 ↗ |